Ezetimibe Therapy for Cardiovascular Risk Reduction

Introduction to Ezetimibe Mechanism and Importance of Consistent Therapy

The American Diabetes Association and other guideline societies recommend ezetimibe combined with statins to reduce myocardial infarctions and stroke in patients with very high cardiovascular risk (moderate to high certainty evidence) 1
The American Heart Association suggests that adding ezetimibe to statin therapy provides a significant relative risk reduction in major adverse cardiovascular events in patients with diabetes, as demonstrated by the IMPROVE-IT trial 2

For patients with diabetes and additional cardiovascular risk factors, consistent ezetimibe therapy helps achieve target LDL-C levels, according to the American College of Cardiology and the European Society of Cardiology 2
In patients with established atherosclerotic cardiovascular disease (ASCVD), maintaining consistent ezetimibe therapy is critical for secondary prevention, as recommended by the American Heart Association 4
For patients with statin intolerance, ezetimibe may be the primary lipid-lowering therapy, making adherence even more crucial, as suggested by the European Atherosclerosis Society 5

The European Society of Cardiology recommends taking ezetimibe at the same time each day to establish a routine, and setting medication reminders on your phone or using pill organizers to improve adherence 6
Combination therapy options may be considered for patients taking multiple medications, to simplify the treatment regimen and improve adherence, as recommended by the American College of Cardiology 6